|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder |
| 化学式 | C31H39Cl2N5 |
|||
| 分子量 | 552.58 | CAS No. | 1872387-43-3 | |
| Solubility (25°C)* | 体外 | Ethanol | 49 mg/mL (88.67 mM) | |
| DMSO | 7 mg/mL (12.66 mM) | |||
| Water | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | DC661は強力なパルミトイルプロテインチオエステラーゼ1(PPT1)阻害剤です。DC661は、HCQよりもはるかに優れた能力でリソソームを脱酸し、オートファジーを阻害します。DC661はアポトーシスを誘発します。 |
|---|---|
| in vitro | Treatment of melanoma cells with DC661 results in a more striking accumulation of the autophagic vesicle marker LC3B-II at lower concentrations compared with either Lys05 or HCQ, reflecting more pronounced accumulation of autophagic vesicles at concentrations between 0.1 and 10 μmol/L. All cells die at concentrations above 10 μmol/L for this compound in contrast to Lys05 and HCQ. Compared with HCQ or Lys05, this compound treatment induces a significantly more potent inhibition of autophagic flux in melanoma cells expressing the mCherry-eGFP-LC3B reporter, and significantly higher levels of free GFP in melanoma cells expressing GFP-LC3B. This compound treatment resulted in significantly greater lysosomal deacidification compared with either HCQ or Lys05. The IC50 of this chemical in 72-hour MTT assays is 100-fold lower than that of HCQ across multiple cancer cell lines including colon and pancreas cancer cell lines. This compound suppresses long-term clonogenic growth of melanoma cells more effectively and induces significantly more apoptosis than Lys05, HCQ, or combined BRAF and MEK inhibition in BRAF-mutant melanoma cells. |
| in vivo | Treatment with the reduced dose (3 mg/kg, i.p.) of DC661 in a HT29 xenograft results in a significant reduction in tumor volume and almost complete suppression of daily tumor growth rate compared with control mice without significantly affecting mouse weight. |
| 細胞アッセイ | 細胞株 | A375P cells |
|---|---|---|
| 濃度 | 0.1, 0.3, 1, 3, 10 μM | |
| 反応時間 | 6 hours | |
| 実験の流れ | A375P cells are treated with doses of HCQ, Lys05, or DC661 for 6 hours before lysates are immunoblotted. |
|
| 動物実験 | 動物モデル | HT29 colorectal xenograft |
| 投薬量 | 3 mg/kg | |
| 投与方法 | i.p. |
|
| The AKT-USP15 axis modulates autophagy in MPP+-induced Parkinson's disease model of SN4741 cells [ Cell Signal, 2025, 134:111879] | PubMed: 40441471 |
| Divergent effects of acute and chronic PPT1 inhibition in melanoma [ Autophagy, 2024, 1-13.] | PubMed: 39265628 |
| E3 ubiquitin ligase TRIM2 identified as a novel suppressor of CYP11B2 and aldosterone production [ Cell Mol Life Sci, 2024, 82(1):27] | PubMed: 39725733 |
| Lysosomal lipid peroxidation regulates tumor immunity [ J Clin Invest, 2023, 133(8)e164596] | PubMed: 36795483 |
| Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer [ Cell Death Discov, 2023, 9(1):457] | PubMed: 38102129 |
| ASCL2 Maintains Stemness Phenotype through ATG9B and Sensitizes Gliomas to Autophagy Inhibitor [ Adv Sci (Weinh), 2022, 9(27):e2105938] | PubMed: 35882624 |
| Calenduloside E protects against myocardial ischemia-reperfusion injury induced calcium overload by enhancing autophagy and inhibiting L-type Ca2+ channels through BAG3 [ Biomed Pharmacother, 2022, 145:112432] | PubMed: 34798472 |
| SYVN1-mediated ubiquitination and degradation of MSH3 promotes the apoptosis of lens epithelial cells [ FEBS J, 2022, 10.1111/febs.16447] | PubMed: 35334159 |
| Poly (ADP-ribose) polymerase 1-mediated defective mitophagy contributes to painful diabetic neuropathy in the db/db model [ J Neurochem, 2022, 10.1111/jnc.15606] | PubMed: 35263449 |
| ER proteins decipher the tubulin code to regulate organelle distribution [ Nature, 2021, 10.1038/s41586-021-04204-9] | PubMed: 34912111 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。